Neurogene Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Neurogene granted non-qualified stock options for an aggregate of 12,555 shares to four new employees as an employment inducement material to their entry into the company. The grants were approved by the Compensation Committee under the Company’s 2025 Inducement Plan and Nasdaq Listing Rule 5635(c)(4), with an exercise price equal to the closing price on the grant date.
Key figures
- New hires
- 4
- Shares granted
- 12555
- Vesting term years
- 4
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.